Skip to main content
SpringerLink
Log in

Lungenembolie-Prophylaxe

Kein Vorteil durch Vena-cava-Filter in Ergänzung zur Antikoagulation

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Carrier M et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010; 152: 578–589

    Article  PubMed  Google Scholar 

  2. Kearon C et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: 419–94.

    Article  Google Scholar 

  3. Stein PD et al. Impact of vena cava filters on in- hospital case fatality rate from pulmonary embolism. Am J Med 2012; 125: 478–84.

    Article  PubMed  Google Scholar 

  4. The PREPIC study group: Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC ( Prevention du Risque d Émbolie Pulmonaire par Interruption Cave) randomized study, Circulation 2005; 112: 416–22.

    Article  Google Scholar 

Literatur

  • Mismetti P, Laporte S, Pellerin O et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 2015; 313(16):1627–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Robert-Koch-Klinik, Pneumologie, Nikolai-Rumjanzew-Straße 100, 04207, Leipzig, Deutschland

    Kathleen Gutjahr (Leitende Oberärztin)

Authors
  1. Kathleen Gutjahr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathleen Gutjahr.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gutjahr, K. Kein Vorteil durch Vena-cava-Filter in Ergänzung zur Antikoagulation. Pneumo News 7, 32–33 (2015). https://doi.org/10.1007/s15033-015-0225-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0225-5

Search

Navigation